Moreover, we found higher T-tau and P-tau levels with some SVD markers in APOE ε4/4 carriers in patients with MCI, reflecting the importance of SVD markers in an early stage of dementia, possibly contributing to the dementia pathophysiology. The gene discussed is MAPT; the disease is dementia.